ChartMill assigns a Buy % Consensus number of 69% to MNTA. The Buy consensus is the weighted average rating of the current analysts ratings.
The consensus rating for Momenta Pharma (MNTA) is 68.8 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering Momenta Pharma (MNTA) is 9.